Ranjith Ramasamy is a consultant urologist at Jumeirah American Clinic in Dubai, UAE,[3][4] and the former Director of the Reproductive Urology Fellowship program at the University of Miami's Miller School of Medicine.
[5][6][7] An American medical researcher and urologist, Ramasamy is known for academic contributions to reproductive medicine, including testosterone deficiency, regenerative therapy, erectile dysfunction, and prostate cancer studies.
His work, along with other researchers, has been published in The World Journal of Men's Health,[20] contributed to understanding of the COVID-19 infection and its relation to causing the underlying endothelial dysfunction, a condition in which the small blood vessels fail to perform normally and damage male erectile system.
[24][25] In September 2021, based on the previous work "Phase II Randomized, Clinical Trial Evaluating 2 Schedules of Low-Intensity Shockwave Therapy for the Treatment of Erectile Dysfunction",[26] Ramasamy became a principal researcher for the “Combined Shockwave Therapy and Platelet Rich Plasma for the Treatment of Erectile Dysfunction” study that is funded by a three-year grant provided by the National Institutes of Health.
[27] In 2023, Ramasamy received the Gold Cystoscope Award for creative impactful work in andrology, mentorship, clinical scholarship and research.